BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 25203449)

  • 1. High need for MMR vaccination in HIV infected adults in Austria.
    Grabmeier-Pfistershammer K; Poeppl W; Herkner H; Touzeau-Roemer V; Huschka E; Rieger A; Burgmann H
    Vaccine; 2014 Oct; 32(45):6020-3. PubMed ID: 25203449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of antibodies to measles, mumps, and rubella, and serologic responses after vaccination among human immunodeficiency virus (HIV)-1 infected adults in Northern Thailand.
    Chaiwarith R; Praparattanapan J; Nuket K; Kotarathitithum W; Supparatpinyo K
    BMC Infect Dis; 2016 Apr; 16():190. PubMed ID: 27138005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do HIV-positive adult immigrants need to be screened for measles-mumps-rubella and varicella zoster virus immunization?
    Llenas-García J; Rubio R; Hernando A; Arrazola P; Pulido F
    AIDS Care; 2013 Aug; 25(8):980-9. PubMed ID: 23244745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early loss of measles antibodies after MMR vaccine among HIV-infected adults receiving HAART.
    Belaunzarán-Zamudio PF; García-León ML; Wong-Chew RM; Villasís-Keever A; Cuellar-Rodríguez J; Mosqueda-Gómez JL; Muñoz-Trejo T; Escobedo K; Santos JI; Ruiz-Palacios GM; Sierra-Madero JG
    Vaccine; 2009 Nov; 27(50):7059-64. PubMed ID: 19799846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term safety and serologic response to measles, mumps, and rubella vaccination in HIV-1 infected adults.
    Stermole BM; Grandits GA; Roediger MP; Clark BM; Ganesan A; Weintrob AC; Crum-Cianflone NF; Ferguson TM; Macalino GE; Landrum ML
    Vaccine; 2011 Apr; 29(16):2874-80. PubMed ID: 21352938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to measles, mumps, and rubella revaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy.
    Aurpibul L; Puthanakit T; Sirisanthana T; Sirisanthana V
    Clin Infect Dis; 2007 Sep; 45(5):637-42. PubMed ID: 17683001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low tetanus, diphtheria and acellular pertussis (Tdap) vaccination coverage among HIV infected individuals in Austria.
    Grabmeier-Pfistershammer K; Herkner H; Touzeau-Roemer V; Rieger A; Burgmann H; Poeppl W
    Vaccine; 2015 Jul; 33(32):3929-32. PubMed ID: 26102535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of highly active antiretroviral therapy on the serological response to additional measles vaccinations in human immunodeficiency virus-infected children.
    Berkelhamer S; Borock E; Elsen C; Englund J; Johnson D
    Clin Infect Dis; 2001 Apr; 32(7):1090-4. PubMed ID: 11264038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy.
    Sultana R; Rahman MM; Hassan Z; Hassan MS
    Scand J Immunol; 2006 Dec; 64(6):684-9. PubMed ID: 17083626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased measles-mumps-rubella (MMR) vaccine uptake in the context of a targeted immunisation campaign during a measles outbreak in a vaccine-reluctant community in England.
    Le Menach A; Boxall N; Amirthalingam G; Maddock L; Balasegaram S; Mindlin M
    Vaccine; 2014 Feb; 32(10):1147-52. PubMed ID: 24440207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measles, mumps, rubella and VZV: importance of serological testing of vaccine-preventable diseases in young adults living with HIV in Germany.
    Schwarze-Zander C; Draenert R; Lehmann C; Stecher M; Boesecke C; Sammet S; Wasmuth JC; Seybold U; Gillor D; Wieland U; Kümmerle T; Strassburg CP; Mankertz A; Eis-Hübinger AM; Jäger G; Fätkenheuer G; Bogner JR; Rockstroh JK; Vehreschild JJ
    Epidemiol Infect; 2017 Jan; 145(2):236-244. PubMed ID: 27780480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term immunity to measles, mumps and rubella after MMR vaccination among children with bone marrow transplants.
    Spoulou V; Giannaki M; Vounatsou M; Bakoula C; Grafakos S
    Bone Marrow Transplant; 2004 Jun; 33(12):1187-90. PubMed ID: 15077129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measles, mumps and rubella: control by vaccination.
    van Druten JA; de Boo T; Plantinga AD
    Dev Biol Stand; 1986; 65():53-63. PubMed ID: 3556777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of measles vaccination in HIV infected children].
    Ołdakowska A; Marczyńska M; Szczepańska-Putz M
    Przegl Epidemiol; 2001; 55(4):523-7. PubMed ID: 11921741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96].
    Stohrer-Draxl P; Amstad H; Grize L; Gassner M; Takken-Sahli K; Bourquin C; Braun-Fahrländer C
    Praxis (Bern 1994); 1999 Jun; 88(24):1069-77. PubMed ID: 10420798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: loss of specific antibodies against attenuated vaccine strains and natural viral infection.
    Bekker V; Scherpbier H; Pajkrt D; Jurriaans S; Zaaijer H; Kuijpers TW
    Pediatrics; 2006 Aug; 118(2):e315-22. PubMed ID: 16847077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of measles, mumps, and rubella vaccine in patients with DiGeorge syndrome.
    Al-Sukaiti N; Reid B; Lavi S; Al-Zaharani D; Atkinson A; Roifman CM; Grunebaum E
    J Allergy Clin Immunol; 2010 Oct; 126(4):868-9. PubMed ID: 20810153
    [No Abstract]   [Full Text] [Related]  

  • 18. Detection of serum antibodies against measles, mumps and rubella after primary measles, mumps and rubella (MMR) vaccination in children.
    Rafiei Tabatabaei S; Esteghamati AR; Shiva F; Fallah F; Radmanesh R; Abdinia B; Shamshiri AR; Khairkhah M; Shekari Ebrahimabad H; Karimi A
    Arch Iran Med; 2013 Jan; 16(1):38-41. PubMed ID: 23273235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and risk factors of measles seronegativity in a cohort of HIV-positive subjects: a retrospective study.
    Dauby N; Martin C; Hainaut M; Grammens T; Van den Wijngaert S; Delforge M; De Wit S
    HIV Med; 2018 Jul; 19(6):426-429. PubMed ID: 29573535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rubella, rubeola, and mumps in pregnant women: susceptibilities and strategies for testing and vaccinating.
    Haas DM; Flowers CA; Congdon CL
    Obstet Gynecol; 2005 Aug; 106(2):295-300. PubMed ID: 16055578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.